CIMEX
Price
$26.05
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
131.88B
IFAFX
Price
$26.16
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
131.88B
Interact to see
Advertisement

CIMEX vs IFAFX

Header iconCIMEX vs IFAFX Comparison
Open Charts CIMEX vs IFAFXBanner chart's image
American Funds Income Fund of Amer 529E
Price$26.05
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets131.88B
American Funds Income Fund of Amer F1
Price$26.16
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets131.88B
CIMEX vs IFAFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CIMEX vs. IFAFX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMEX is a Buy and IFAFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMEX (132B) and IFAFX (132B) have equal amount of cash in the bank . IFAFX (3.70) and CIMEX (3.52) have matching dividends . CIMEX was incepted earlier than IFAFX: CIMEX (23 years) vs IFAFX (24 years). CIMEX (0.84) is less costly to investors than IFAFX (0.65). CIMEX (92.00) and IFAFX (92.00) have comparable annual turnover. CIMEX (250) and IFAFX (250) have matching initial minimum investment requirements. IFAFX (12.38) and CIMEX (12.12) have marching annual gain over last year. CIMEX return over 5 years is better than : 40.35 vs. IFAFX (35.75).
CIMEXIFAFXCIMEX / IFAFX
Total Expense Ratio0.840.65129%
Annual Report Gross Expense Ratio0.840.65129%
Fund Existence23 years24 years-
Gain YTD8.0768.22298%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets132B132B100%
Annual Yield % from dividends3.523.7095%
Returns for 1 year12.1212.3898%
Returns for 3 years17.3115.79110%
Returns for 5 years40.3535.75113%
Returns for 10 years63.8242.49150%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKDA4.790.17
+3.68%
Arcadia Biosciences
MRBK13.190.29
+2.25%
Meridian Corp
RGLS8.100.15
+1.89%
Regulus Therapeutics
BCRX10.97-0.07
-0.63%
BioCryst Pharmaceuticals
CVNA343.30-2.34
-0.68%
Carvana Co